Epigenetic control of inducible gene expression in the immune system

Epigenomics

Volumn 2, Issue 6, 2010, Pages 775-795

  Lim, Pek Siew ^a   Shannon, M Frances ^a   Hardy, Kristine ^a  

^a Australian National University   (Australia)

Author keywords

chromatin; histone modification; immune system; inducible gene

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE H3; HISTONE METHYLTRANSFERASE; RNA POLYMERASE II; UNTRANSLATED RNA;

CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURFACE; CHROMATIN STRUCTURE; CPG ISLAND; DNA BINDING; DNA METHYLATION; EFFECTOR CELL; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MEMORY CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 78650468957     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.55     Document Type: Review

References (152)

1. Grady WM, Parkin RK, Mitchell PS et al.: Epigenetic silencing of the intronic microRNA Hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27(27), 3880-3888 (2008)
2. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K: Development of monocytes, macrophages, and dendritic cells. Science 327(5966), 656-661 (2010).
3. Sitnicka E: From the bone marrow to the thymus: the road map of early stages of T-cell development. Crit. Rev. Immunol. 29(6), 487-530 (2009).
4. Parra M: Epigenetic events during B lymphocyte development. Epigenetics 4(7), 462-468 (2009).
5. Bernstein BE, Meissner A, Lander ES: The mammalian epigenome. Cell 128(4), 669-681 (2007).
6. Navarro F, Lieberman J: Small RNAs guide hematopoietic cell differentiation and function. J. Immunol. 184(11), 5939-5947 (2010).
7. Jacquier A: The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat. Rev. Genet. 10(12), 833-844 (2009).
8. Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10(5), 295-304 (2009).
9. Kouzarides T: Chromatin modifications and their function. Cell 128(4), 693-705 (2007).
10. Lee BM, Mahadevan LC: Stability of histone modifications across mammalian genomes: implications for epigenetic marking. J. Cell. Biochem. 108(1), 22-34 (2009).
11. Li B, Carey M, Workman JL: The role of chromatin during transcription. Cell 128(4), 707-719 (2007).
12. Talbert PB, Henikoff S: Histone variants - ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell. Biol. 11(4), 264-275 (2010).
13. Clapier CR, Cairns BR: The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78, 273-304 (2009).
14. Barski A, Cuddapah S, Cui K et al.: High-resolution profiling of histone methylations in the human genome. Cell 129(4), 823-837 (2007).
15. Cui K, Zang C, Roh TY et al.: Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4(1), 80-93 (2009).
16. Mikkelsen TS, Ku M, Jaffe DB et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007).
17. Roh TY, Ngau WC, Cui K, Landsman D, Zhao K: High-resolution genome-wide mapping of histone modifications. Nat. Biotechnol. 22(8), 1013-1016 (2004).
18. Wang Z, Zang C, Rosenfeld JA et al.: Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40(7), 897-903 (2008).
19. Heintzman ND, Stuart RK, Hon G et al.: Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39(3), 311-318 (2007).
20. Roh TY, Cuddapah S, Cui K, Zhao K: The genomic landscape of histone modifications in human T cells. Proc. Natl Acad. Sci. USA 103(43), 15782-15787 (2006).
21. Roh TY, Cuddapah S, Zhao K: Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev. 19(5), 542-552 (2005).
22. Schones DE, Cui K, Cuddapah S et al.: Dynamic regulation of nucleosome positioning in the human genome. Cell 132(5), 887-898 (2008).
23. Azuara V, Perry P, Sauer S et al.: Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8(5), 532-538 (2006).
24. Pokholok DK, Harbison CT, Levine S et al.: Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122(4), 517-527 (2005).
25. Sinha I, Wiren M, Ekwall K: Genome-wide patterns of histone modifications in fission yeast. Chromosome Res. 14(1), 95-105 (2006).
26. Schubeler D, MacAlpine DM, Scalzo D et al.: The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18(11), 1263-1271 (2004).
27. Bernstein BE, Kamal M, Lindblad-Toh K et al.: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2), 169-181 (2005).
28. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130(1), 77-88 (2007).
29. Koch CM, Andrews RM, Flicek P et al.: The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 17(6), 691-707 (2007).
30. Kim TH, Barrera LO, Zheng M et al.: A high-resolution map of active promoters in the human genome. Nature 436(7052), 876-880 (2005).
31. Liu CL, Kaplan T, Kim M et al.: Single-nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol. 3(10), E328 (2005).
32. Martens JH, OSullivan RJ, Braunschweig U et al.: The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24(4), 800-812 (2005).
33. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R, Zhang MQ: Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10, 143 (2009).
34. Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
35. Delaval K, Govin J, Cerqueira F, Rousseaux S, Khochbin S, Feil R: Differential histone modifications mark mouse imprinting control regions during spermatogenesis. EMBO J. 26(3), 720-729 (2007).
36. Strahl BD, Allis CD: The language of covalent histone modifications. Nature 403(6765), 41-45 (2000).
37. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA: Histone H3 lysine 9 methylation and HP1g are associated with transcription elongation through mammalian chromatin. Mol. Cell 19(3), 381-391 (2005).
38. Bannister AJ, Schneider R, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T: Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. J. Biol. Chem. 280(18), 17732-17736 (2005).
39. Farris SD, Rubio ED, Moon JJ, Gombert WM, Nelson BH, Krumm A: Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J. Biol. Chem. 280(26), 25298-25303 (2005).
40. Rao B, Shibata Y, Strahl BD, Lieb JD: Dimethylation of histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin genome-wide. Mol. Cell. Biol. 25(21), 9447-9459 (2005).
41. Vakoc CR, Sachdeva MM, Wang H, Blobel GA: Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol. 26(24), 9185-9195 (2006).
42. Edmunds JW, Mahadevan LC, Clayton AL: Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 27(2), 406-420 (2008).
43. Carrozza MJ, Li B, Florens L et al.: Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123(4), 581-592 (2005).
44. Wang Z, Zang C, Cui K et al.: Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138(5), 1019-1031 (2009).
45. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev. 16(1), 6-21 (2002).
46. Suzuki MM, Bird A: DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9(6), 465-476 (2008).
47. Khulan B, Thompson RF, Ye K et al.: Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16(8), 1046-1055 (2006).
48. Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ: CpG islands recruit a histone H3 lysine 36 demethylase. Mol. Cell 38(2), 179-190 (2010).
49. Bouwman P, Philipsen S: Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 195(1-2), 27-38 (2002).
50. Zelko IN, Mueller MR, Folz RJ: CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic. Biol. Med. 48(7), 895-904 (2010).
51. Orford K, Kharchenko P, Lai W et al.: Differential H3K4 methylation identifies developmentally poised hematopoietic genes. Dev. Cell 14(5), 798-809 (2008).
52. Hargreaves DC, Horng T, Medzhitov R: Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138(1), 129-145 (2009).
53. Kuo CT, Leiden JM: Transcriptional regulation of T lymphocyte development and function. Annu. Rev. Immunol. 17, 149-187 (1999).
54. Santana MA, Esquivel-Guadarrama F: Cell biology of T cell activation and differentiation. Int. Rev. Cytol. 250, 217-274 (2006).
55. Ullman KS, Northrop JP, Verweij CL, Crabtree GR: Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8, 421-452 (1990).
56. Herschman HR: Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60, 281-319 (1991).
57. Lim PS, Hardy K, Bunting KL et al.: Defining the chromatin signature of inducible genes in T cells. Genome Biol. 10(10), R107 (2009).
58. Barski A, Jothi R, Cuddapah S et al.: Chromatin poises miRNA- and protein-coding genes for expression. Genome Res. 19(10), 1742-1751 (2009).
59. Ramirez-Carrozzi VR, Braas D, Bhatt DM et al.: A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138(1), 114-128 (2009).
60. Roh TY, Zhao K: High-resolution, genome-wide mapping of chromatin modifications by GMAT. Methods Mol. Biol. 387, 95-108 (2008).
61. Muse GW, Gilchrist DA, Nechaev S et al.: RNA polymerase is poised for activation across the genome. Nat. Genet. 39(12), 1507-1511 (2007).
62. Radonjic M, Andrau JC, Lijnzaad P et al.: Genome-wide analyses reveal RNA polymerase II located upstream of genes poised for rapid response upon S. cerevisiae stationary phase exit. Mol. Cell 18(2), 171-183 (2005).
63. Zeitlinger J, Stark A, Kellis M et al.: RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 39(12), 1512-1516 (2007).
64. OBrien T, Lis JT: RNA polymerase II pauses at the 5 end of the transcriptionally induced Drosophila hsp70 gene. Mol. Cell. Biol. 11(10), 5285-5290 (1991).
65. Rougvie AE, Lis JT: The RNA polymerase II molecule at the 5 end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54(6), 795-804 (1988).
66. Lis J: Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation. Cold Spring Harb. Symp. Quant. Biol. 63, 347-356 (1998).
67. Margaritis T, Holstege FC: Poised RNA polymerase II gives pause for thought. Cell 133(4), 581-584 (2008).
68. Saunders A, Core LJ, Lis JT: Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7(8), 557-567 (2006).
69. Gilchrist DA, Nechaev S, Lee C et al.: NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly. Genes Dev. 22(14), 1921-1933 (2008).
70. Lee C, Li X, Hechmer A et al.: NELF and GAGA factor are linked to promoter-proximal pausing at many genes in Drosophila. Mol. Cell. Biol. 28(10), 3290-3300 (2008).
71. Hendrix DA, Hong JW, Zeitlinger J, Rokhsar DS, Levine MS: Promoter elements associated with RNA Pol II stalling in the Drosophila embryo. Proc. Natl Acad. Sci. USA 105(22), 7762-7767 (2008).
72. Krumm A, Hickey LB, Groudine M: Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev. 9(5), 559-572 (1995).
73. Wu CH, Yamaguchi Y, Benjamin LR et al.: NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev. 17(11), 1402-1414 (2003).
74. Yamaguchi Y, Takagi T, Wada T et al.: NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97(1), 41-51 (1999).
75. Fuda NJ, Ardehali MB, Lis JT: Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461(7261), 186-192 (2009).
76. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM: NF-kB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8(2), 327-337 (2001).
77. Eberhardy SR, Farnham PJ: Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277(42), 40156-40162 (2002).
78. Kanazawa S, Okamoto T, Peterlin BM: Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12(1), 61-70 (2000).
79. Simone C, Stiegler P, Bagella L et al.: Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 21(26), 4137-4148 (2002).
80. Anderson P: Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 10(1), 24-35 (2010).
81. Curtale G, Citarella F, Carissimi C et al.: An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115(2), 265-273 (2010).
82. Androulidaki A, Iliopoulos D, Arranz A et al.: The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31(2), 220-231 (2009).
83. Gan Q, Yoshida T, McDonald OG, Owens GK: Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25(1), 2-9 (2007).
84. Byun JS, Wong MM, Cui W et al.: Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc. Natl Acad. Sci. USA 106(46), 19286-19291 (2009).
85. Juelich T, Sutcliffe E, Denton A et al.: Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J. Immunol. 183(11), 7063-7072 (2009).
86. Smith JL, Freebern WJ, Collins I et al.: Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proc. Natl Acad. Sci. USA 101(32), 11554-11559 (2004).
87. Aung HT, Schroder K, Himes SR et al.: LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 20(9), 1315-1327 (2006).
88. Ghisletti S, Barozzi I, Mietton F et al.: Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32(3), 317-328 (2010).
89. Smith AE, Chronis C, Christodoulakis M et al.: Epigenetics of human T cells during the G0->G1 transition. Genome Res. 19(8), 1325-1337 (2009).
90. Liang MD, Zhang Y, McDevit D, Marecki S, Nikolajczyk BS: The interleukin-1b gene is transcribed from a poised promoter architecture in monocytes. J. Biol. Chem. 281(14), 9227-9237 (2006).
91. Saccani S, Pantano S, Natoli G: p38-dependent marking of inflammatory genes for increased NF-k B recruitment. Nat. Immunol. 3(1), 69-75 (2002).
92. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G: The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130(6), 1083-1094 (2007).
93. Attema JL, Reeves R, Murray V et al.: The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T-cell activation. J. Immunol. 169(5), 2466-2476 (2002).
94. Brettingham-Moore KH, Sprod OR, Chen X, Oakford P, Shannon MF, Holloway AF: Determinants of a transcriptionally competent environment at the GM-CSF promoter. Nucleic Acids Res. 36(8), 2639-2653 (2008).
95. Chen X, Wang J, Woltring D, Gerondakis S, Shannon MF: Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol. Cell. Biol. 25(8), 3209-3219 (2005).
96. Rao A, Avni O: Molecular aspects of T-cell differentiation. Br. Med. Bull. 56(4), 969-984 (2000).
97. Rao S, Procko E, Shannon MF: Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167(8), 4494-4503 (2001).
98. Zhao K, Wang W, Rando OJ et al.: Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95(5), 625-636 (1998).
99. Ishihara S, Varma R, Schwartz RH: A new fractionation assay, based on the size of formaldehyde-crosslinked, mildly sheared chromatin, delineates the chromatin structure at promoter regions. Nucleic Acids Res. 38(11), E124 (2010).
100. Liu H, Mulholland N, Fu H, Zhao K: Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Mol. Cell. Biol. 26(7), 2550-2559 (2006).
101. Sutcliffe EL, Parish IA, He YQ et al.: Dynamic histone variant exchange accompanies gene induction in T cells. Mol. Cell. Biol. 29(7), 1972-1986 (2009).
102. Tamura T, Smith M, Kanno T, Dasenbrock H, Nishiyama A, Ozato K: Inducible deposition of the histone variant H3.3 in interferon-stimulated genes. J. Biol. Chem. 284(18), 12217-12225 (2009).
103. Schwartz BE, Ahmad K: Transcriptional activation triggers deposition and removal of the histone variant H3.3. Genes Dev. 19(7), 804-814 (2005).
104. Jin C, Felsenfeld G: Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev. 21(12), 1519-1529 (2007).
105. Lau LF, Nathans D: Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl Acad. Sci. USA 84(5), 1182-1186 (1987).
106. Heintzman ND, Hon GC, Hawkins RD et al.: Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459(7243), 108-112 (2009).
107. Kouskouti A, Talianidis I: Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J. 24(2), 347-357 (2005).
108. Northrop JK, Wells AD, Shen H: Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J. Immunol. 181(2), 865-868 (2008).
109. Araki Y, Wang Z, Zang C et al.: Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8(+) T cells. Immunity 30(6), 912-925 (2009).
110. Mirabella F, Baxter EW, Boissinot M, James SR, Cockerill PN: The human IL-3/granulocyte-macrophage colony-stimulating factor locus is epigenetically silent in immature thymocytes and is progressively activated during T-cell development. J. Immunol. 184(6), 3043-3054 (2010).
111. Cuddapah S, Barski A, Zhao K: Epigenomics of T-cell activation, differentiation, and memory. Curr. Opin. Immunol. 22, 1-7 (2010).
112. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F: Memory and flexibility of cytokine gene expression as separable properties of human T(h)1 and T(h)2 lymphocytes. Nat. Immunol. 4(1), 78-86 (2003).
113. Avni O, Rao A: T cell differentiation: a mechanistic view. Curr. Opin. Immunol. 12(6), 654-659 (2000).
114. Fujita N, Jaye DL, Geigerman C et al.: MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119(1), 75-86 (2004).
115. Gao H, Lukin K, Ramirez J, Fields S, Lopez D, Hagman J: Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc. Natl Acad. Sci. USA 106(27), 11258-11263 (2009).
116. Chi TH, Wan M, Lee PP et al.: Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19(2), 169-182 (2003).
117. Jani A, Wan M, Zhang J et al.: A novel genetic strategy reveals unexpected roles of the Swi-Snf-like chromatin-remodeling BAF complex in thymocyte development. J. Exp. Med. 205(12), 2813-2825 (2008).
118. Williams CJ, Naito T, Arco PG et al.: The chromatin remodeler Mi-2b is required for CD4 expression and T-cell development. Immunity 20(6), 719-733 (2004).
119. Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T: The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J. Exp. Med. 198(12), 1937-1949 (2003).
120. Zhang F, Boothby M: T helper type 1-specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-g promoter are Stat4 dependent. J. Exp. Med. 203(6), 1493-1505 (2006).
121. Wurster AL, Pazin MJ: BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells. Mol. Cell. Biol. 28(24), 7274-7285 (2008).
122. Gyory I, Wu J, Fejer G, Seto E, Wright KL: PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5(3), 299-308 (2004).
123. Tachibana M, Sugimoto K, Fukushima T, Shinkai Y: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276(27), 25309-25317 (2001).
124. Agarwal S, Rao A: Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9(6), 765-775 (1998).
125. Agarwal S, Viola JP, Rao A: Chromatin-based regulatory mechanisms governing cytokine gene transcription. J. Allergy Clin. Immunol. 103(6), 990-999 (1999).
126. Agarwal S, Avni O, Rao A: Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 12(6), 643-652 (2000).
127. Schoenborn JR, Dorschner MO, Sekimata M et al.: Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-g. Nat. Immunol. 8(7), 732-742 (2007).
128. Miller SA, Huang AC, Miazgowicz MM, Brassil MM, Weinmann AS: Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression. Genes Dev. 22(21), 2980-2993 (2008).
129. Tong Y, Aune T, Boothby M: T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-g promoter via a conserved T-box half-site. Proc. Natl Acad. Sci. USA 102(6), 2034-2039 (2005).
130. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA: Interchromosomal associations between alternatively expressed loci. Nature 435(7042), 637-645 (2005).
131. Spilianakis CG, Flavell RA: Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat. Immunol. 5(10), 1017-1027 (2004).
132. Cai S, Lee CC, Kohwi-Shigematsu T: SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38(11), 1278-1288 (2006).
133. Stock JK, Giadrossi S, Casanova M et al.: Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol. 9(12), 1428-1435 (2007).
134. Noer A, Lindeman LC, Collas P: Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells. Stem Cells Dev. 18(5), 725-736 (2009).
135. Rodriguez CR, Cho EJ, Keogh MC, Moore CL, Greenleaf AL, Buratowski S: Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol. Cell. Biol. 20(1), 104-112 (2000).
136. Wei G, Wei L, Zhu J et al.: Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1), 155-167 (2009).
137. Weishaupt H, Sigvardsson M, Attema JL: Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood 115(2), 247-256 (2010).
138. Mukasa R, Balasubramani A, Lee YK et al.: Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32(5), 616-627 (2010).
139. Celniker SE, Dillon LA, Gerstein MB et al.: Unlocking the secrets of the genome. Nature 459(7249), 927-930 (2009).
140. Perales R, Bentley D: Cotranscriptionality: the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 36(2), 178-191 (2009).
141. Massie CE, Mills IG: ChIPping away at gene regulation. EMBO Rep. 9(4), 337-343 (2008).
142. Impey S, McCorkle SR, Cha-Molstad H et al.: Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119(7), 1041-1054 (2004).
143. Johnson DS, Mortazavi A, Myers RM, Wold B: Genome-wide mapping of in vivo protein-DNA interactions. Science 316(5830), 1497-1502 (2007).
144. Robertson G, Hirst M, Bainbridge M et al.: Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4(8), 651-657 (2007).
145. Schones DE, Zhao K: Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet. 9(3), 179-191 (2008).
146. Wei CL, Wu Q, Vega VB et al.: A global map of p53 transcription-factor binding sites in the human genome. Cell 124(1), 207-219 (2006).
147. Kaufmann SH: The contribution of immunology to the rational design of novel antibacterial vaccines. Nat. Rev. Microbiol. 5(7), 491-504 (2007).
148. Dong C: Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6(4), 329-333 (2006).
149. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24(6), 677-688 (2006).
150. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
151. Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
152. Corthay A: How do regulatory T cells work? Scand. J. Immunol. 70(4), 326-336 (2009).